.svg)
Content management in life sciences is the governed handling of regulated documents and media across pharma, biotech, and medical-device operations — research records, clinical trial documentation, regulatory submissions, quality records, and promotional material — under frameworks like GxP, 21 CFR Part 11, and health-authority submission standards, where every document's integrity and audit history must be provable.
Life sciences content lives under strict controls: 21 CFR Part 11 governs electronic records and signatures (validated systems, audit trails, signature integrity); GxP disciplines demand version control and defensible change history; and submission standards dictate structure and format for regulatory filings. A document's provenance — who created, reviewed, and approved it, and when — is itself regulated data, not metadata.
The volume and criticality make manual control untenable: a single submission assembles thousands of documents that must be current, approved, and traceable. Systems must enforce audit-trailed, controlled workflows, maintain immutable audit trails, control promotional material through medical-legal-regulatory (MLR) review, and increasingly manage rich media — scientific imaging, procedure video, patient-facing content — with the same rigor as text.
ioMoVo provides permission-controlled content management for life sciences — audit-trailed, controlled workflows, immutable logging, and rich-media handling — deployable on-premises or air-gapped where research and patient data cannot leave controlled infrastructure. See the ioMoVo life sciences page.
The FDA regulation governing electronic records and signatures — requiring validated systems, audit trails, and controls that make electronic records as trustworthy as paper.
Medical, legal, and regulatory review of promotional content before use — a controlled, documented approval workflow content systems must enforce.